CLSI C43-A2

CLSI C43-A2

Click here to purchase
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.

This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.

Product Details

Published:
03/01/2010
ISBN(s):
1562387200
File Size:
1 file , 2 MB

You may also like

CLSI VET01S

CLSI VET01S

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 6th Edition, VET01SEd6Estandard by Clinical and...

CLSI EP33

CLSI EP33

Use of Delta Checks in the Medical Laboratory, 2nd Edition, EP33Ed2Estandard by Clinical and Laboratory Standards Institute, 06/01/2023

CLSI EP25-Ed2

CLSI EP25-Ed2

Evaluation of Stability of In Vitro Medical Laboratory Test Reagents, 2nd Edition, EP25Ed2Estandard by Clinical and Laboratory Standards Institute, 04/26/2023

CLSI PRE04

CLSI PRE04

Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations, 1st Edition, PRE04Ed1Estandard by Clinical and Laboratory Standards...

Back to Top